LLY vs SOLV · P/E 39, rev $22.97B vs P/E 9.1, rev $8.32B
Eli Lilly and Company (LLY) versus Solventum Corp. (SOLV) — a side-by-side from cached financials, not a winner call.
Eli Lilly and Company (LLY) is a drug manufacturers - general company listed on NYSE. It is led by David Ricks.
Solventum Corp. (SOLV) is a medical instruments & supplies company listed on NYSE.
Latest reported LLY revenue for 2026-06-30 was $22.97B. Net income was $7.09B. Revenue was up 16.0% from 2026-03-31 to 2026-06-30. LLY currently screens at market cap $991.62B and trailing P/E 39.5.
Latest reported SOLV revenue for 2025-12-31 was $8.32B. Net income was $1.56B. Revenue was up 0.9% from 2024-12-31 to 2025-12-31. SOLV currently screens at market cap $12.91B and trailing P/E 9.1.
LLY currently screens at market cap $991.62B and trailing P/E 39.5. SOLV currently screens at market cap $12.91B and trailing P/E 9.1.
Not investment advice. Open the LLY and SOLV stock pages for the full models.
Not investment advice.